PREVIEW: Fibrates and nicotinic acid by all Sub-ICB Locations
Why it matters: NICE guideline NG238 (cardiovascular disease: risk assessment and reduction, including lipid modification) recommends that fibrates and nicotinic acid should not be routinely offered to patients for the primary or secondary prevention of cardiovascular disease (CVD). This guidance does not apply to people with familial hypercholesterolaemia, which is covered by separate NICE guidance.
Description: Total cost of prescriptions for fibrates and nicotinic acid per 1000 registered patients
Performance: Loading...
Explore:
Tagged as: (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →
Fetching data...